Independent equity research is coming.

Aruan Research is an independent equity-research platform that helps individual investors understand what a company may be worth. It brings research and analysis together in one place, with a focus on clarity rather than noise.

Aruan Research is built for individual investors, from people taking their first steps in the markets to experienced investors who want a second opinion. The presentation adapts to how much finance you already know.

Aruan Research is being built for US and other global equities, Nigerian Exchange stocks, and global ETFs. NGX coverage is in beta, and the market list is still growing before launch.

No. If you are new to investing, Aruan Research explains results in plain language and puts the detailed figures one tap away. If you already work with markets, the full analysis is there when you want it.

Each analysis brings together a valuation estimate, the case for and against the company, key financial information, and a written research summary you can read at your own pace.

No. Aruan Research is built to show you the evidence, the reasoning, and the risks. It does not issue buy, sell, or hold instructions, so the decision stays with you.

Aruan Research has not launched yet. Join the waitlist and we will email you when it opens, or apply to be a beta tester and use the full workstation early.

Join the waitlist with your email. Choose whether you want a launch notification or beta access, and we will take it from there. It takes about ten seconds, and we will not share your address.

Accounts are protected with email verification and secure sign-in flows, and we are careful about what we store. Our privacy policy explains what is collected and how it is used.

No. Aruan Research provides research and educational tools, not personalised investment advice. Every investment carries risk, so review the analysis and consult a qualified professional before making a decision.